CAPR vs IP · $1.62B cap vs P/E 43, $26.62B cap
Capricor Therapeutics Inc (CAPR) versus International Paper (IP) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
International Paper (IP) is a packaging & containers company listed on US.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CAPR currently screens at market cap $1.62B.
IP does not have a complete income-statement cache yet.
CAPR currently screens at market cap $1.62B. IP currently screens at market cap $26.62B and trailing P/E 43.1.
Not investment advice. Open the CAPR and IP stock pages for the full models.
Not investment advice.